Phase 1 Trial of ChAd68 and Ad5 Adenovirus COVID-19 Vaccines Delivered by Aerosol
NCT05094609
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
OTHER
Sponsor class
Conditions
COVID-19
SARS-CoV2 Infection
Interventions
BIOLOGICAL:
Ad5-triCoV/Mac
BIOLOGICAL:
ChAd-triCoV/Mac
Sponsor
McMaster University
Collaborators
[object Object]